Quart Barry D

Insider·Kiniksa Pharmaceuticals International, plc·KNSA·Insider since 2025·Form 4 filings: 9
Trades YTD
5
Trades (12m)
9
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

9 transactions
12 Feb 2026
SOLD
$KNSA
2,690
$45.00
S
10 Feb 2026
SOLD
$KNSA
110
$45.00
S
04 Feb 2026
SOLD
$KNSA
2,602
$45.02
S
03 Feb 2026
SOLD
$KNSA
12,528
$45.27
S
02 Feb 2026
SOLD
$KNSA
830
$45.00
S
15 Dec 2025
SOLD
$KNSA
20,129
$41.51
S
11 Jun 2025
SOLD
$KNSA
12,336
$30.39
S
10 Jun 2025
SOLD
$KNSA
8,212
$30.36
S
09 Jun 2025
SOLD
$KNSA
6,900
$30.26
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Kiniksa Pharmaceuticals International, plc

last 30 days

No active insider cluster at Kiniksa Pharmaceuticals International, plc in the last 30 days. D's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event D is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 10:41 UTC.